Avatrombopag is used to treat thrombocytopenia in adults with persistent liver disease who are arranged to undergo a medical treatment. Avatrombopag is used to treat chronic immune thrombocytopenia when other therapies have failed. Avatrombopag is not a treatment for thrombocytopenia and it will not make your platelet counts normal. Avatrombopag may additionally be used for purposes not noted in this medication guide. Your physician will measure your platelet degrees with a blood test before you start taking avatrombopag. Your physician may periodically change your dosage. Once everyday to deal with persistent immune thrombocytopenia, Avatrombopag is usually taken. When provided before a clinical treatment in people with persistent liver disease: Avatrombopag is usually taken daily for 5 days, starting 10 to 13 days prior to your procedure. You might also require blood tests for a couple of weeks after your last dosage. Keep each tablet in the foil blister pack up until you prepare to take a dosage.
* Please keep in mind that all text is summarized by machine, we do not bear any responsibility, and you should always check original source before taking any actions
** If you believe that content on the Plex is summarised improperly, please, contact us, and we will get rid of it quickly; please, send an email with a brief explanation.